News

Laboratorios Almirall SA v Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)23 January 2009Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other’s patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held […]
Laboratorios Almirall SA -and- Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)23 January 2009Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other’s patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held […]
Virgin Atlantic Airways Ltd v Premium Aircraft Interiors Group Ltd [2009] EWHC 2621 January 2009Richard Meade QC, Henry Ward and Jessie Bowhill appeared for the claimants, Virgin Atlantic, in the trial before Mr. Justice Lewison in November 2008. Virgin brought a claim against Premium Aircraft alleging that that Premium Aircraft Interiors, the manufacturer of its patented flat-bed seat (called ‘the UCS’), had manufactured other seats or kits for other […]
Virgin Atlantic Airways Ltd v Premium Aircraft Interiors Group Ltd and Premium Aircraft Interiors UK Ltd [2009] EWHC 2621 January 2009Richard Meade QC, Henry Ward and Jessie Bowhill appeared for the claimants, Virgin Atlantic, in the trial before Mr. Justice Lewison in November 2008. Virgin brought a claim against Premium Aircraft alleging that that Premium Aircraft Interiors, the manufacturer of its patented flat-bed seat (called ‘the UCS’), had manufactured other seats or kits for other […]
Actavis v Novartis [2009] EWHC 41 (Ch)16 January 2009The trial, held in July 2008, was about a European Patent for a sustained release formulation of a drug called fluvastatin, a type of statin which reduces blood cholesterol. Actavis sought to revoke the patent on the grounds of obviousness and insufficiency. Novartis did not defend the claims as granted but applied to amend. The […]
Actavis v Novartis [2009] EWHC 41 (Ch)16 January 2009The trial, held in July 2008, was about a European Patent for a sustained release formulation of a drug called fluvastatin, a type of statin which reduces blood cholesterol. Actavis sought to revoke the patent on the grounds of obviousness and insufficiency. Novartis did not defend the claims as granted but applied to amend. The […]
Hotel Cipriani SRL v Cipriani (Grosvenor Street) Ltd [2008] EWHC 30329 December 2008The first claimant, the owner of the Cipriani Hotel in Venice successfully brought a claim against the first defendant for trademark infringement and passing off in relation to the London restaurant called ‘Cipriani London’. The first defendant company was run by the sons of Guiseppe Cipriani, one of the founders of the Hotel Cipriani. The […]
Hotel Cipriani SRL v Cipriani (Grosvenor Street) Ltd [2008] EWHC 30329 December 2008The first claimant, the owner of the Cipriani Hotel in Venice successfully brought a claim against the first defendant for trademark infringement and passing off in relation to the London restaurant called ‘Cipriani London’. The first defendant company was run by the sons of Guiseppe Cipriani, one of the founders of the Hotel Cipriani. The […]
Professor Sir Hugh Laddie 1946 – 20084 December 2008Professor Sir Hugh Laddie, a member of 8 New Square for 25 years before becoming a judge, died at home in London on 29th November 2008. His funeral took place at Cheshunt on 30th November. We pay this tribute to him, to which a number of members of chambers who knew and admired him have […]
Charlotte May Appointed Treasury Junior1 December 20088 New Square is pleased to announce that effective from the 1st December 2008 Charlotte May was appointed as Standing Counsel to the Comptroller General for Patents, Designs and Trade Marks.